BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 28397874)

  • 1. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
    Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
    Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
    Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ
    Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
    Liang JF; Chen YT; Fuh JL; Li SY; Chen TJ; Tang CH; Wang SJ
    Cephalalgia; 2015 Mar; 35(3):203-10. PubMed ID: 24853165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
    Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
    J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of proton pump inhibitors and risk of ischemic events in the general population.
    Casula M; Scotti L; Galimberti F; Mozzanica F; Tragni E; Corrao G; Catapano AL
    Atherosclerosis; 2018 Oct; 277():123-129. PubMed ID: 30212680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular Outcomes With Proton Pump Inhibitors and Thienopyridines: A Systematic Review and Meta-Analysis.
    Malhotra K; Katsanos AH; Bilal M; Ishfaq MF; Goyal N; Tsivgoulis G
    Stroke; 2018 Feb; 49(2):312-318. PubMed ID: 29339434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
    Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
    Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
    Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
    Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study.
    Foresta A; Fernandez LO; Torrigiani G; Schena S; Roncaglioni MC; Nobili A; Tettamanti M; Franchi C; Fortino I; Succurro E; Sesti G; Baviera M
    Drugs Aging; 2024 Mar; 41(3):239-249. PubMed ID: 38367169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.
    Charlot M; Ahlehoff O; Norgaard ML; Jørgensen CH; Sørensen R; Abildstrøm SZ; Hansen PR; Madsen JK; Køber L; Torp-Pedersen C; Gislason G
    Ann Intern Med; 2010 Sep; 153(6):378-86. PubMed ID: 20855802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
    Mahabaleshwarkar RK; Yang Y; Datar MV; Bentley JP; Strum MW; Banahan BF; Null KD
    Curr Med Res Opin; 2013 Apr; 29(4):315-23. PubMed ID: 23362935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
    Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
    PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
    Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
    Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study.
    Charlot M; Grove EL; Hansen PR; Olesen JB; Ahlehoff O; Selmer C; Lindhardsen J; Madsen JK; Køber L; Torp-Pedersen C; Gislason GH
    BMJ; 2011 May; 342():d2690. PubMed ID: 21562004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitor use and the risk for Parkinson's disease: A nationwide population-based study in Taiwan.
    Chen HL; Lei WY; Wang JH; Bair MJ; Chen CL
    Medicine (Baltimore); 2023 May; 102(19):e33711. PubMed ID: 37171333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
    Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients With Type 2 Diabetes.
    Geng T; Chen JX; Zhou YF; Lu Q; Wan Z; Liu L; Pan A; Liu G
    J Clin Endocrinol Metab; 2023 May; 108(6):e216-e222. PubMed ID: 36573284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
    Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
    Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.